17-18122185-C-T
Variant summary
Our verdict is Pathogenic. The variant received 16 ACMG points: 16P and 0B. PVS1PP5_Very_Strong
The NM_016239.4(MYO15A):c.3385C>T(p.Arg1129*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000409 in 1,613,028 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_016239.4 stop_gained
Scores
Clinical Significance
Conservation
Publications
- autosomal recessive nonsyndromic hearing loss 3Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), PanelApp Australia
- nonsyndromic genetic hearing lossInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- hearing loss, autosomal recessiveInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 16 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152226Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000965 AC: 24AN: 248778 AF XY: 0.0000591 show subpopulations
GnomAD4 exome AF: 0.0000424 AC: 62AN: 1460802Hom.: 0 Cov.: 44 AF XY: 0.0000454 AC XY: 33AN XY: 726708 show subpopulations
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152226Hom.: 0 Cov.: 33 AF XY: 0.0000403 AC XY: 3AN XY: 74360 show subpopulations
ClinVar
Submissions by phenotype
not provided Pathogenic:4
Identified with a second variant in patients with suspected autosomal recessive sensorineural hearing loss in published literature (PMID: 27068579, 34515852); Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 34426522, 31589614, 38523675, 34515852, 27068579) -
- -
- -
This sequence change creates a premature translational stop signal (p.Arg1129*) in the MYO15A gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in MYO15A are known to be pathogenic (PMID: 17546645). This variant is present in population databases (rs748868741, gnomAD 0.04%). This premature translational stop signal has been observed in individual(s) with deafness (PMID: 27068579). ClinVar contains an entry for this variant (Variation ID: 505802). For these reasons, this variant has been classified as Pathogenic. -
Autosomal recessive nonsyndromic hearing loss 3 Pathogenic:2Other:1
- -
Variant interpreted as Likely pathogenic and reported on 03-02-2019 by Lab or GTR ID 26957. GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. -
- -
Rare genetic deafness Pathogenic:1
The p.Arg1129X variant in MYO15A has been previously reported in at least 2 individuals with hearing loss (Sommen 2016, LMM unpublished data). One individual had a second likely pathogenic MYO15A variant identified, though phasing was not performed (LMM unpublished data). This variant has been identified in 0.04% (14/34518) of Latino chromosomes bygnomAD (http://gnomad.broadinstitute.org); however, its frequency is low enough to be consistent with a carrier frequency for hearing loss. This nonsense variant leads to a premature termination codon at position 1129, which is predicted to lead to a truncated or absent protein. Loss of MYO15A gene function is an established disease mechanism in autosomal recessive hearing loss. In summary, this variant meets criteria to be classified as pathogenic for autosomal recessive hearing loss. ACMG/AMP criteria applied: PVS1, PM2_Supporting, PM3_Supporting. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at